Concord Medical Services Holdings Limited - ADR Peer Comparison

$4.35

$-0.33 (-7.05%)

As on 08-Sep-2026 16:10EDT

Market cap

$20 Mln

Revenue (TTM)

$448 Mln

P/E Ratio

--

P/B Ratio

3

Div. Yield

0 %

Edit

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Market cap ($ Mln)	20	126
Revenue (CN¥ Mln)	461	513
Net Profit (CN¥ Mln)	-92.81	-59.11
Net Margin (%)	-51.55	-11.53
RoE (%)	4.23	-11.09
Price to Earnings	--	--
Price-To-Book	3.00	1.26

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (CN¥ Mln)

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Operating Revenue	460.51	539.57
Cost of Revenue	434.69	136.65
Gross Profit	25.82	402.91
Operating Expenses	265.15	457.76
Operating Profit (EBIT)	-239.33	-54.85
Other Income	--	--
Profit before Tax	-373.36	-53.79
Provision for Tax	6.06	1.56
Profit after Tax (Net Income)	-92.81	-55.35
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities (CN¥ Mln)

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Shareholder's Funds	-2,103.11	535.60
Minority Interest	--	--
Non-Current Liabilities	2,742.84	38.16
Current Liabilities	1,954.41	247.14
Total Liabilities	6,547.36	820.90

Assets (CN¥ Mln)

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Non-Current Assets	5,605.45	81.84
Current Assets	941.91	739.06
Total Assets	6,547.36	820.90
Total Debt*	3,634.99	43.15
Net Current Assets	-1,012.50	491.61

Cashflow (CN¥ Mln)

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Cash From Operating Activities	-201.82	-28.44
Cash Flow from Investing Activities	53.97	-4.39
Cash from Financing Activities	197.23	1.90
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
ROCE (%)	-5.83	-9.13
ROE (%)	4.23	-9.91
ROA (%)	-1.40	-6.49
EBIT Margin (%)	--	--
Net Margin (%)	-20.15	-10.26
Cash Profit Margin (%)	--	--

Growth Ratios

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Revenue Growth (%)	0.20	0.05
EBIT Growth (%)	--	--
Net Profit Growth (%)	69.89	84.03
EPS Growth (%)	-268.36	-15.40
Book Value Growth (%)	--	--

Valuation Ratios

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Price / Earnings	-0.01	-0.38
Price / Book Value	0.00	0.04
Dividend Yield (%)	--	--
EV/EBITDA	-46.50	13.04
Market Cap ($ Cr)	--	--

Solvency Ratios

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Debt to Equity	-1.73	0.08
Short term debt to equity ratio	-0.49	0.03
Current Ratio	0.48	2.99
Quick Ratio	0.46	2.76
Interest Coverage	-1.45	-1,792.00

Operating Efficiency Ratios

	Concord Medical Services Holdings Limited - ADR	Burning Rock Biotech (BNR)
Debtors to sales (%)	9.57	33.74
Asset Turnover	0.07	0.63
Receivable days	37.76	120.32
Inventory Days	33.36	148.04
Payable days	133.89	99.58
Cash Conversion Cycle	-62.77	168.77

Annual
Quarterly